Senior Director, DMPK Project Leader

Company hidden

Boston, MA Full-time Posted 30+ days ago
The company Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. The company’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. The company's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological,…

See the company and apply

Unlock to see who’s hiring, read the full description and apply on the company site.

Checking access…

Explore related jobs

Want more roles like this? Browse fresh jobs or tailor your resume with AI.